ADAPT-AST (Adaptive Antimicrobial Susceptibility Testing)
ADAPT-AST
Adaptive Prediction of Antimicrobial Susceptibility and Its Implementation to Improve the Management of Urinary Tract Infection
1 other identifier
observational
500,000
1 country
1
Brief Summary
The goal of this study is to improve the way urinary tract infections (UTIs) are tested for antibiotic resistance. The main questions it aims to answer are:
- Can the investigators use a method called Bayesian causal inference to create or check clinical prediction models that help predict if certain antibiotics will work for a urinary infection, using patient information from the National Health Service (NHS)?
- Can this new ADAPT-AST method, which uses data and a smarter approach, do a better job of testing for urinary infection than the old methods? Will it help doctors make quicker decisions and save resources by being more efficient? Participants in this study will not be receiving treatments. The study will involve: Using statistical methods to predict UTI test results based on patient data. Evaluating whether this new approach can provide doctors with more timely and useful information for treating UTIs. Assessing whether it can help save money and resources in the lab and pharmacy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 8, 2024
CompletedFirst Posted
Study publicly available on registry
March 7, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedFebruary 4, 2025
November 1, 2024
1.2 years
February 8, 2024
January 31, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The overall number of susceptible results per panel available at day 1
The overall number of susceptible results per panel available at day 1
2 years
Secondary Outcomes (7)
The number of susceptible results per panel available for WHO AWaRe Access category agents at day 1
2 years
The number of susceptible results per panel for orally-administrable agents available at day 1
2 years
The number of susceptible results per panel for intravenously-administrable agents available at day 1
2 years
The proportion of panels with no results available for WHO AWaRe Access category agents at day 1
2 years
The proportion of panels with no susceptible results of any kind available at day 1
2 years
- +2 more secondary outcomes
Eligibility Criteria
Patients with a suspected Urinary Tract Infection
You may qualify if:
- o The specimens for which AST predictions \& recommendations will be made are urine specimens processed by LCL Microbiology laboratory taken from patients ≥ 18 years old in LUHFT and/or GP locations that grew organisms within the period of the study dataset; these are the only specimens for which AST results will be available to train and test ADAPT-AST. Predictions will be made for all urine specimen types, including mid-stream urines, catheter specimens of urine and nephrostomy urine.
You may not qualify if:
- Urine specimens processed by LCL that did not grow organisms within the period of the study dataset
- Urine specimens taken from patients \< 18 years old
- Predictions will be made for asymptomatic bacteriuria screening specimens in pregnant women who have had specimens sent from a GP, but not those which have been sent from Liverpool Womens' NHS Foundation Trust (LWfT) Predictions for non-bacterial organisms grown in urine (i.e., fungi) will not be made.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Liverpool University Hospitals NHS Foundation Trust
Liverpool, North West, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2024
First Posted
March 7, 2024
Study Start
September 1, 2024
Primary Completion
December 1, 2025
Study Completion
March 1, 2026
Last Updated
February 4, 2025
Record last verified: 2024-11